These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12894612)

  • 1. Correlates of therapeutic response in panic disorder presenting with palpitations: heart rate variability, sleep, and placebo effect.
    Baker B; Khaykin Y; Devins G; Dorian P; Shapiro C; Newman D
    Can J Psychiatry; 2003 Jul; 48(6):381-7. PubMed ID: 12894612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonazepam in the treatment of panic disorder: a double-blind, placebo-controlled trial investigating the correlation between clonazepam concentrations in plasma and clinical response.
    Beauclair L; Fontaine R; Annable L; Holobow N; Chouinard G
    J Clin Psychopharmacol; 1994 Apr; 14(2):111-8. PubMed ID: 8195451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages.
    Moroz G; Rosenbaum JF
    J Clin Psychiatry; 1999 Sep; 60(9):604-12. PubMed ID: 10520979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind clonazepam vs placebo in panic disorder treatment.
    Valença AM; Nardi AE; Nascimento I; Mezzasalma MA; Lopes FL; Zin W
    Arq Neuropsiquiatr; 2000 Dec; 58(4):1025-9. PubMed ID: 11105068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the pharmacotherapy of sleep bruxism: placebo-controlled polysomnographic and psychometric studies with clonazepam.
    Saletu A; Parapatics S; Saletu B; Anderer P; Prause W; Putz H; Adelbauer J; Saletu-Zyhlarz GM
    Neuropsychobiology; 2005; 51(4):214-25. PubMed ID: 15915004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonazepam treatment of panic disorder in patients with recurrent chest pain and normal coronary arteries.
    Wulsin LR; Maddock R; Beitman B; Dawaher R; Wells VE
    Int J Psychiatry Med; 1999; 29(1):97-105. PubMed ID: 10376236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early coadministration of clonazepam with sertraline for panic disorder.
    Goddard AW; Brouette T; Almai A; Jetty P; Woods SW; Charney D
    Arch Gen Psychiatry; 2001 Jul; 58(7):681-6. PubMed ID: 11448376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of clonazepam on quality of life and work productivity in panic disorder.
    Jacobs RJ; Davidson JR; Gupta S; Meyerhoff AS
    Am J Manag Care; 1997 Aug; 3(8):1187-96. PubMed ID: 10170301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
    Schweizer E; Patterson W; Rickels K; Rosenthal M
    Am J Psychiatry; 1993 Aug; 150(8):1210-5. PubMed ID: 8328566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of 24-Hour Heart Rate Variability among Panic Disorder Patients without Previous Drug Treatment and Comorbid Disorders.
    Gündüz N; Akpınar Aslan E; Eren F; Sodan Turan H; Öztürk M; Tural Ü
    Turk Psikiyatri Derg; 2019; 30(4):236-244. PubMed ID: 32594484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic response to benzodiazepine in panic disorder subtypes.
    Valença AM; Nardi AE; Mezzasalma MA; Nascimento I; Zin WA; Lopes FL; Versiani M
    Sao Paulo Med J; 2003 Mar; 121(2):77-80. PubMed ID: 12870055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks.
    Nardi AE; Valença AM; Nascimento I; Mezzasalma MA; Zin WA
    Psychiatry Res; 2000 May; 94(2):179-84. PubMed ID: 10808043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
    Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD
    Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon dioxide induced panic attacks and short term clonazepam treatment. Preliminary study.
    Nardi AE; Valença AM; Zin W; Nascimento I
    Arq Neuropsiquiatr; 1999 Jun; 57(2B):361-5. PubMed ID: 10450339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
    Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
    J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam.
    Nardi AE; Valença AM; Nascimento I; Lopes FL; Mezzasalma MA; Freire RC; Veras AB; Zin WA; Versiani M
    Psychiatry Res; 2005 Nov; 137(1-2):61-70. PubMed ID: 16226812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon dioxide test as an additional clinical measure of treatment response in panic disorder.
    Valença AM; Nardi AE; Nascimento I; Zin WA; Versiani M
    Arq Neuropsiquiatr; 2002 Jun; 60(2-B):358-61. PubMed ID: 12131931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sildenafil on sleep respiratory parameters and heart rate variability in obstructive sleep apnea.
    Neves C; Tufik S; Monteiro MA; Chediek F; Jose FF; Roizenblatt S
    Sleep Med; 2010 Jun; 11(6):545-51. PubMed ID: 20472498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal and daytime panic attacks--comparison of sleep architecture, heart rate variability, and response to sodium lactate challenge.
    Sloan EP; Natarajan M; Baker B; Dorian P; Mironov D; Barr A; Newman DM; Shapiro CM
    Biol Psychiatry; 1999 May; 45(10):1313-20. PubMed ID: 10349038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.